Business ❯ Pharmaceutical Industry

Market Competition

Drug Pricing Pricing Strategies Novo Nordisk Eli Lilly Generic Drugs Drug Approval Weight Loss Drugs Drug Sales Drug Development Drug Launches

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

The once-daily peptide offers biologic-like efficacy without injections.

Stories older than 24h

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

Novo’s CagriSema Falls Short of Lilly’s Tirzepatide in 84-Week Head‑to‑Head Trial

Bayer Sues J&J Over Erleada Marketing, Alleging False Superiority Claims Versus Nubeqa

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

Mexican Court Revives Denosumab Patent, Extends Amgen Exclusivity to 2027

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Trump Unveils TrumpRx.gov, a Government Coupon Site for Cheaper Prescriptions

FTC Reaches 10-Year Settlement With Express Scripts to Cut Insulin Costs and Reshape PBM Practices

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Strive Compounding Sues Lilly and Novo, Alleging Antitrust Push to Block Compounded GLP-1s

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

Delhi High Court Allows Zydus to Market Nivolumab Biosimilar on Public‑Interest Grounds

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

FDA Approves First Oral Wegovy Weight-Loss Pill as U.S. Availability Begins